Avalo Therapeutics, Inc. — Director's Dealing 2020

Dec 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerecor Inc. (CERC)
CIK: 0001534120
Period of Report: 2020-12-10

Reporting Person: NEIL GARRY ARTHUR (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-10	Common Stock	P	3599	$2.278	Acquired	77680	Direct

Footnotes

F1: These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.